Chem. Biodiversity 2018, 15, e1800013
Mass Spectrometry’, J. Agric. Food Chem. 2000, 48,
5702 – 5709.
[17] S. Antus, A. Gottsegen, P. Kolonits, H. Wagner, ‘Total Syn-
thesis of Two Naturally Occurring Neolignans of Potential
Biological Activity’, Liebigs Ann. Chem. 1989, 593 – 594.
[18] N. Neuner-Jehle, F. Etzweiler, in ‘Perfumes: Art, Science
[2] G. F. Gerberick, C. A. Ryan, P. S. Kern, H. Schlatter, R. J.
Dearman, I. Kimber, G. Y. Patlewicz, D. A. Basketter, ‘Compi-
lation of Historical Local Lymph Node Data for Evaluation
of Skin Sensitization Alternative Methods’, Dermatitis 2005,
16, 157 – 202.
[3] A. Schnuch, W. Uter, J. Geier, H. Lessmann, P. J. Frosch,
‘Sensitization to 26 Fragrances to be Labelled According to
Current European Regulation. Results of the IVDK and
Review of the Literature’, Contact Dermatitis 2007, 57,
1 – 10.
€
and Technology’, Eds. P. M. Muller and D. Lamparsky,
Springer Netherlands, Amsterdam, 1991, pp. 153 – 212.
[19] R. Emter, G. Ellis, A. Natsch, ‘Performance of a Novel ker-
atinocyte-based Reporter Cell Line to Screen Skin Sensitiz-
ers In Vitro’, Toxicol. Appl. Pharmacol. 2010, 245,
281 – 290.
[20] A. Natsch, H. Gfeller, ‘LC-MS-Based Characterization of the
Peptide Reactivity of Chemicals to Improve the In Vitro
Prediction of the Skin Sensitization Potential’, Toxicol. Sci.
2008, 106, 464 – 478.
[4] W. Uter, J. Geier, P. Frosch, A. Schnuch, ‘Contact Allergy to
Fragrances: Current Patch Test Results (2005 – 2008) from
the Information Network of Departments of Dermatology’,
Contact Dermatitis 2010, 63, 254 – 261.
[21] S. F. Martin, ‘Allergic Contact Dermatitis: Xenoinflammation
of the Skin’, Curr. Opin. Immunol. 2012, 24, 720 – 729.
€
€
[5] I. Ojima, ‘Fluorine in Medicinal Chemistry and Chemical
Biology’, John Wiley & Sons, Ltd., Chichester, UK, 2009.
[6] D. Michel, M. Schlosser, ‘Odor–Structure Relationships
[22] A.-T. Karlberg, M. A. Bergstrom, A. Borje, K. Luthman, J. L.
G. Nilsson, ‘Allergic Contact Dermatitis-Formation, Struc-
tural Requirements, and Reactivity of Skin Sensitizers’,
Chem. Res. Toxicol. 2008, 21, 53 – 69.
Using Fluorine as
a Probe’, Tetrahedron 2000, 56,
4253 – 4260.
[23] D. A. Basketter, L. Blaikie, R. J. Dearman, I. Kimber, C. A.
Ryan, G. F. Gerberick, P. Harvey, P. Evans, I. R. White, R. J.
G. Rycroft, ‘Use of the Local Lymph Node Assay for the
Estimation of Relative Contact Allergenic Potency’, Contact
Dermatitis 2000, 42, 344 – 348.
[24] G. Patlewicz, S. Casati, D. A. Basketter, D. Asturiol, D. W.
Roberts, J.-P. Lepoittevin, A. P. Worth, K. Aschberger, ‘Can
currently Available Non-Animal Methods Detect Pre and
Pro-haptens Relevant for Skin Sensitization?’, Regul. Toxicol.
Pharmacol. 2016, 82, 147 – 155.
[7] M. Schlosser, ‘Introduction of Fluorine Into Organic Mole-
cules: Why and How’, Tetrahedron 1978, 34, 3 – 17.
[8] M. Schlosser, D. Michel, ‘About the “Physiological Size” of
Fluorine Substituents: Comparison of Sensorially Active
Compounds with Fluorine and Methyl Substituted Ana-
logues’, Tetrahedron 1996, 52, 99 – 108.
[9] R. Callejo, M. J. Corr, M. Yang, M. Wang, D. B. Cordes, A. M.
Z. Slawin, D. O’Hagan, ‘Fluorinated Musk Fragrances: The
CF2 Group as a Conformational Bias Influencing the Odour
of Civetone and (R)-Muscone’, Chem. Eur. J. 2016, 22,
8137 – 8151.
[25] OECD, ‘OECD Guideline for the Testing of Chemicals, Sec-
tion 4: Test No. 442D: In Vitro Skin Sensitisation: ARE-Nrf2
Luciferase Test Method’, 2015.
€
[10] M. J. Corr, R. A. Cormanich, C. N. von Hahmann, M. Buhl,
D. B. Cordes, A. M. Z. Slawin, D. O’Hagan, ‘Fluorine in Fra-
grances: Exploring the Difluoromethylene (CF2) Group as a
Conformational Constraint in Macrocyclic Musk Lactones’,
Org. Biomol. Chem. 2016, 14, 211 – 219.
[26] OECD, ‘OECD Guideline for the Testing of Chemicals, Sec-
tion 4: Test No. 442E: In Vitro Skin Sensitisation: human
Cell Line Activation Test (h-CLAT)’, 2016.
[27] OECD, ‘OECD Guideline for the Testing of Chemicals, Sec-
tion 4: Test No. 442C: In Chemico Skin Sensitisation: Direct
Peptide Reactivity Assay (DPRA)’, 2015.
[28] A. Natsch, R. Emter, H. Gfeller, T. Haupt, G. Ellis, ‘Predicting
Skin Sensitizer Potency Based on In Vitro Data from Ker-
atinoSens and Kinetic Peptide Binding: Global Versus
Domain-Based Assessment’, Toxicol. Sci. 2015, 143, 319 – 332.
[29] A. Natsch, R. Emter, ‘Reporter Cell Lines for Skin Sensitiza-
tion Testing’, Arch. Toxicol. 2015, 89, 1645 – 1668.
[30] G. F. Gerberick, J. D. Vassallo, R. E. Bailey, J. G. Chaney, S.
W. Morrall, J.–. P. Lepoittevin, ‘Development of a Peptide
Reactivity Assay for Screening Contact Allergens’, Toxicol.
Sci. 2004, 81, 332 – 343.
[31] C. L. Wong, A.-L. Lam, M. T. Smith, S. Ghassabian, ‘Evalua-
tion of a High-Throughput Peptide Reactivity Format Assay
for Assessment of the Skin Sensitization Potential of
Chemicals’, Front. Pharmacol. 2016, 7, 53.
[32] I. B. Niklasson, D. J. Ponting, K. Luthman, A.-T. Karlberg,
‘Bioactivation of Cinnamic Alcohol Forms Several
Strong Skin Sensitizers’, Chem. Res. Toxicol. 2014, 27,
568 – 575.
ꢁ
[11] D. Guerin, I. Dez, A.-C. Gaumont, X. Pannecoucke, S.
Couve-Bonnaire, ‘Access to Constrained Fluoropseudopep-
tides via Ring-Closing Metathesis of Fluoroalkenes’, Org.
Lett. 2016, 18, 3606 – 3609.
ꢁ
[12] E. Barde, A. Guerinot, J. Cossy, ‘Cobalt-Catalyzed Cross-
Coupling of a-Bromo Amides with Grignard Reagents’, Org.
Lett. 2017, 19, 6068 – 6071.
[13] K. Kasten, A. M. Z. Slawin, A. D. Smith, ‘Enantioselective
Synthesis of b-Fluoro-b-aryl-a-aminopentenamides by
Organocatalytic [2,3]-Sigmatropic Rearrangement’, Org.
Lett. 2017, 19, 5182 – 5185.
[14] P. Wheeler, H. U. Vora, T. Rovis, ‘Asymmetric NHC-catalyzed
Synthesis of a-fluoroamides from Readily Accessible
a-fluoroenals’, Chem. Sci. 2013, 4, 1674 – 1679.
[15] Y. Li, X. Liu, D. Ma, B. Liu, H. Jiang, ‘Silver-Assisted Difunc-
tionalization of Terminal Alkynes: Highly Regio- and Stere-
oselective Synthesis of Bromofluoroalkenes’, Adv. Synth.
Catal. 2012, 354, 2683 – 2688.
[16] T. Konno, A. Ikemoto, T. Ishihara, ‘A New Entry to the Con-
struction of a Quaternary Carbon Center Having a Fluorine
atom-SN20 Reaction of c-fluoroallylic Alcohol Derivatives
with Various Cyanocuprates’, Org. Biomol. Chem. 2012, 10,
8154 – 8163.
[33] E. Moss, C. Debeuckelaere, V. Berl, K. Elbayed, F.-M.
Moussallieh, I.-J. Namer, J.-P. Lepoittevin, ‘In Situ
Metabolism of Cinnamyl Alcohol in Reconstructed Human
(12 of 13) e1800013
© 2018 Wiley-VHCA AG, Zurich, Switzerland